Direkt zum Inhalt
Merck

Fortfahren mit

MAB941

Anti-Coxsackievirus B4 Antibody, clone 371-3D-7H-6G

ascites fluid, clone 371-3D-7H-6G, Chemicon®

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
PackungsgrößeSKUVerfügbarkeitPreis

Über diesen Artikel

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
371-3D-7H-6G, monoclonal
Species reactivity:
human
Application:
IF
Citations:
5
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


biological source

mouse

Quality Level

antibody form

ascites fluid

antibody product type

primary antibodies

clone

371-3D-7H-6G, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG2b

shipped in

wet ice

Application

Detect Coxsackievirus B4 using this Anti-Coxsackievirus B4 Antibody, clone 371-3D-7H-6G validated for use in IF.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Suggested starting dilution for IFA is 1:1000.

Dilute with buffer pH 7.5 -8.0 containing protein or other stabilizing medium. Final working dilutions must be determined by end user.

Biochem/physiol Actions

Reacts with Coxsackie virus B4. Neutralizes Coxsackie virus B4 JVB strain at a titer of 1:524288.

Physical form

Ascites.

Preparation Note

Maintain at -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
MAB947MAB8256MAB8661
antibody form

ascites fluid

antibody form

ascites fluid

antibody form

ascites fluid

antibody form

ascites fluid

species reactivity

human

species reactivity

human

species reactivity

human

species reactivity

human

clone

371-3D-7H-6G, monoclonal

clone

450-11G-8A-5E, monoclonal

clone

9B3.2, monoclonal

clone

B2, monoclonal, B4, monoclonal

biological source

mouse

biological source

mouse

biological source

mouse

biological source

mouse

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable

technique(s)

immunofluorescence: suitable


Still not finding the right product?

Probieren Sie unser Produkt-Auswahlhilfe, um Ihre Auswahl einzugrenzen


Lagerklasse

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Persistence of coxsackievirus B4 infection in rhabdomyosarcoma cells for 30 months. Brief report.
G Frisk, M A Lindberg, H Diderholm, H Oiderholm
Archives of Virology null
Evidence for coxsackievirus infection in primary Sjogren's syndrome.
Antigoni Triantafyllopoulou, Nikos Tapinos, Haralampos M Moutsopoulos
Arthritis and Rheumatism null
Jing Dai et al.
Emerging microbes & infections, 12(2), 2261560-2261560 (2023-09-19)
Coxsackievirus B4 (CVB4) has one of the highest proportions of fatal outcomes of other enterovirus serotypes. However, the pathogenesis of severe respiratory disease caused by CVB4 infection remains unclear. In this study, 3 of 42 (7.2%, GZ-R6, GZ-R7 and GZ-R8)



Global Trade Item Number

SKUGTIN
MAB94104053252580000

Questions

Reviews

No rating value

Active Filters